Cara Therapeutics

-$0.20 (-1.66%) Today

$0.00 (0.00%) As of 9:12 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CARA and other ETFs, options, and stocks.

About CARA

CARA Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing and commercializing new chemical entities designed to alleviate pruritus by selectively targeting peripheral kappa opioid receptors (KORs). Its portfolio includes opioid-based products, anesthetic-based drugs, and analgesics that targets to alleviate itch and pain.

CEO

Derek T. Chalmers

Employees

Headquarters

Stamford, Connecticut

Founded

2004

CARA Key Statistics

Market Cap

673.23M

Price-Earnings Ratio

51.78

Dividend Yield

—

Average Volume

441.31K

High Today

$12.08

Low Today

$11.58

Open Price

$12.02

Volume

390.13K

52 Week High

$29.65

52 Week Low

$11.58

Analyst Ratings

88%

of 8 ratings

Buy

87.5%

Hold

12.5%

Sell

CARA Earnings

-$0.67

$0.08

$0.84

$1.59

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Q2 FY21

Estimated

— per share

Actual

Expected Aug 9, After Hours